EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Chimeric antigen receptor T-cell therapy for refractory systemic autoimmune rheumatological diseases

Mads Lamm Larsen, Anne Voss, Christoffer Tandrup Holst Nielsen, Ellen-Margrethe Hauge, Mikkel Faurschou, Anne Troldborg

Ugeskrift for Læger · 2024

DOI: 10.61409/v06240429 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ugeskrift for Læger, 2024. Verfasst von Mads Lamm Larsen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Afdelingen for Led- og Bindevævssygdomme, Aarhus Universitetshospital. Hauptthemen laut MEDLINE: Rheumatic Diseases, Autoimmune Diseases, Receptors, Chimeric Antigen, Immunotherapy, Adoptive. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor T-cell (CAR-T) therapy is emerging as a novel treatment for systemic autoimmune rheumatic diseases. To date, CAR-T therapy in rheumatology has been reported only in case studies and conference abstracts, but clinical trial results are forthcoming. Current evidence indicates a rapid and highly effective therapeutic response with a favourable side effect profile, suggesting that CD19 CAR-T therapy could be beneficially established for these conditions. Initially, CAR-T therapy appears relevant for a select group of severe, treatment-resistant rheumatic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rheumatic DiseasesAutoimmune DiseasesReceptors, Chimeric AntigenImmunotherapy, AdoptiveHumansReceptors, Antigen, T-CellAntigens, CD19T-LymphocytesLupus Erythematosus, Systemic

Substanzen

Receptors, Chimeric AntigenReceptors, Antigen, T-CellAntigens, CD19

Autor:innen und Institutionen

  • Afdelingen for Led- og Bindevævssygdomme, Aarhus Universitetshospital.
  • Institut for Biomedicin, Aarhus Universitet.
  • Reumatologisk Afdeling, Odense Universitetshospital.
  • Afdeling for Rygkirurgi, Led- og Bindevævssygdomme, Københavns Universitetshospital - Rigshospitalet.
  • Klinisk Institut, Aarhus Universitet.

Zitieren

APA

Larsen, M. L., Voss, A., Nielsen, C. T. H., Hauge, E. M., Faurschou, M., & Troldborg, A. (2024). Chimeric antigen receptor T-cell therapy for refractory systemic autoimmune rheumatological diseases. Ugeskrift for Læger. https://doi.org/10.61409/v06240429

Vancouver

Larsen ML, Voss A, Nielsen CTH, Hauge EM, Faurschou M, Troldborg A. Chimeric antigen receptor T-cell therapy for refractory systemic autoimmune rheumatological diseases. Ugeskrift for Læger. 2024. doi:10.61409/v06240429

BibTeX
@article{Larsen2024,
  author = {Larsen, Mads Lamm and Voss, Anne and Nielsen, Christoffer Tandrup Holst and Hauge, Ellen-Margrethe and Faurschou, Mikkel and Troldborg, Anne},
  title = {Chimeric antigen receptor T-cell therapy for refractory systemic autoimmune rheumatological diseases},
  journal = {Ugeskrift for Læger},
  year = {2024},
  doi = {10.61409/v06240429}
}
Kostenlos starten →